Seminars in Nuclear Medicine
Volume 32, Issue 3 , Pages 212-213 , July 2002

18F-fluorodeoxyglucose positron emission tomography: False-positive lung scan

Edited by Robert C. Stadalnik

  • A.H. Khandani

      Affiliations

    • Department of Nuclear Medicine Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY. USA
    • ,
  • S.M. Keller

      Affiliations

    • Department of Cardiothoracic Surgery, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY. USA
    • ,
  • M.D. Blaufox

      Affiliations

    • Department of Nuclear Medicine Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY. USA
    • Corresponding Author InformationAddress reprint requests to M. Donald Blaufox, MD, PhD, Department of Nuclear, Medicine, Montefiore Medical Park, 1695A Eastchester Road, Bronx, NY 10461.

References 

  1. discussion Roberts PF, Follette DM, von Haag D, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg. 2000;70:1159–1160
  2. Saunders CA, Dussek JE, O'Doherty MJ, et al. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg. 1999;67:790–797
  3. Mortensen J, Enevoldsen H, Friberg L, et al. 4. Preliminary findings of a prospective study of FDG-PET in patients with possible lung cancer. Clin Positron Imaging. 2000;3:158
  4. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET. Findings in 10 cases. Radiology. 2000;216:117–121
  5. Higashi K, Ueda Y, Sakuma T, et al. Comparison of [(18)f]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med. 2001;42:1489–1496
  6. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: A prospective study. J Nucl Med. 1990;31:1927–1932
  7. Dewan NA, Gupta NC, Redepenning LS, et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest. 1993;104:997–1002
  8. Graeber GM, Gupta NC, Murray GF. Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease. J Thorac Cardiovasc Surg. 1999;117:719–727
  9. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37:943–948
  10. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075–1084
  11. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 1993;188:487–490
  12. Hung GU, Shiau YC, Tsai SC, et al. Differentiation of radiographically indeterminate solitary pulmonary nodules with [18F]fluoro-2-deoxyglucose positron emission tomography. Jpn J Clin Oncol. 2001;31:51–54
  13. Hoekstra CJ, Hoekstra OS, Teengs JP, et al. Thoracic actinomycosis imaging with fluorine-18-fluorodeoxyglucose positron emission tomography. Clin Nucl Med. 1999;24:529–530

PII: S0001-2998(02)80006-X

doi: 10.1053/snuc.2002.124179

Seminars in Nuclear Medicine
Volume 32, Issue 3 , Pages 212-213 , July 2002

Article Tools